Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000520108 | SCV000616727 | uncertain significance | not provided | 2017-08-11 | criteria provided, single submitter | clinical testing | The A1577V variant in the FLNB gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The A1577V variant is observed in 12/10340 (0.12%) alleles from individuals of African background, in the ExAC dataset (Lek et al., 2016). The A1577V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret A1577V as a variant of uncertain significance. |
Fulgent Genetics, |
RCV002476050 | SCV002780165 | uncertain significance | Atelosteogenesis type III; Atelosteogenesis type I; Boomerang dysplasia; Spondylocarpotarsal synostosis syndrome; Larsen syndrome | 2021-07-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000520108 | SCV003267438 | benign | not provided | 2023-10-17 | criteria provided, single submitter | clinical testing |